The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
865484410 8654844 10 F 20120905 20160810 20120709 20160816 EXP US-GLAXOSMITHKLINE-A0983628A GLAXOSMITHKLINE 43.78 YR F Y 0.00000 20160816 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
865484410 8654844 1 PS FLOLAN EPOPROSTENOL SODIUM 1 Unknown 35 NG/KG/MIN CONTINOUS45,000 NG/ML CONCENTRATIONVIAL STRENGTH 1.5 MG U M099 20444 35 DF POWDER FOR INFUSION
865484410 8654844 2 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U M197 20444 POWDER FOR INFUSION
865484410 8654844 3 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U M240 20444 POWDER FOR INFUSION
865484410 8654844 4 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U N513 20444 POWDER FOR INFUSION
865484410 8654844 5 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U N644 20444 POWDER FOR INFUSION
865484410 8654844 6 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U P267 20444 POWDER FOR INFUSION
865484410 8654844 7 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U S276 20444 POWDER FOR INFUSION
865484410 8654844 8 SS FLOLAN EPOPROSTENOL SODIUM 1 35.5 NG/KG/MIN U S925 20444 POWDER FOR INFUSION
865484410 8654844 9 SS FLOLAN EPOPROSTENOL SODIUM 1 Unknown UNK UNK, CO U T662 20444 POWDER FOR INFUSION
865484410 8654844 10 SS FLOLAN EPOPROSTENOL SODIUM 1 35.5 NG/KG/MIN 45,000 NG/ML CONCENTRATION VIAL STRENGTH 1.5 MG, CO U Z606 20444 35.5 DF POWDER FOR INFUSION
865484410 8654844 11 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U UNKNOWN 0 SOLUTION FOR INJECTION
865484410 8654844 12 C REVATIO SILDENAFIL CITRATE 1 U 0
865484410 8654844 13 C LASIX FUROSEMIDE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
865484410 8654844 1 Cor pulmonale chronic
865484410 8654844 2 Pulmonary hypertension
865484410 8654844 11 Pulmonary hypertension

Outcome of event

Event ID CASEID OUTC COD
865484410 8654844 HO
865484410 8654844 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
865484410 8654844 Adverse event
865484410 8654844 Anal incontinence
865484410 8654844 Asthma
865484410 8654844 Chest discomfort
865484410 8654844 Chest pain
865484410 8654844 Device related infection
865484410 8654844 Diarrhoea
865484410 8654844 Dyspnoea
865484410 8654844 Fatigue
865484410 8654844 Flushing
865484410 8654844 Headache
865484410 8654844 Hyperhidrosis
865484410 8654844 Lower respiratory tract infection
865484410 8654844 Lower respiratory tract infection viral
865484410 8654844 Productive cough
865484410 8654844 Renal failure
865484410 8654844 Urticaria

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
865484410 8654844 1 20090130 0
865484410 8654844 2 20090130 0
865484410 8654844 3 20090130 0
865484410 8654844 4 20090130 0
865484410 8654844 5 20090130 0
865484410 8654844 6 20090130 0
865484410 8654844 7 20090130 0
865484410 8654844 9 20090130 0
865484410 8654844 10 20090302 0